Request for Information for Cancer Medicines

Date of Request for Information (RFI): 22nd May 2026 Closing date for Request for Information (RFI): 12th June 2026 UNICEF Supply UNICEF is a United Nations organisation that is committed to promoting the rights and wellbeing of all children worldwide. Together with our partners, we work in 190 countries and territories to translate that commitment into practical action, focusing special effort on reaching the most vulnerable and excluded children, to the benefit of all children, everywhere. UNICEF Supply Division has its headquarters in Copenhagen Denmark. Supplies are essential to fulfil children’s rights. Supporting child survival and development programmes around the world, UNICEF-procured supplies are critical in providing for children’s health, education and protecting them from abuse, exploitation, and neglect. In 2025, UNICEF procured US$5.677 billion worth of supplies and services for children in 164 countries and territories, including US$167 million in pharmaceuticals. In 2024, UNICEF procured US$5.610 billion worth of supplies and services in 160 countries and territories, including US$148.6 million in pharmaceuticals. From 2025 till Q1 2026 UNICEF procured cancer medicines worth about US$ 8.09 million. These figures provide general context on UNICEF procurement activity and are included for information purposes only. Description of requirements: Through this Request for Information, UNICEF seeks information from eligible suppliers on the availability of cancer medicines in order to inform market assessment, sourcing strategy and potential future procurement planning. UNICEF is particularly interested in information on products that fall under one of the following regulatory pathways or oversight categories: Products authorised by a regulatory authority recognised by WHO as a WHO Listed Authority (WLA) for the relevant product stream and regulatory function(s), such as registration and marketing authorisation and/or regulatory inspection. https://www.who